Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Craig A. Johnson Insider Profile
4 Followers
Craig A. Johnson, Director at Mirati Therapeutics, holds 0.00 shares in Mirati Therapeutics (Ticker: MRTX), holds 12.00K shares in La Jolla Pharma (Ticker: LJPC), holds 3.00K shares in Odonate Inc (Ticker: ODTCD).
Craig A. Johnson Mirati Therapeutics (MRTX)Director
Mirati Therapeutics (MRTX)
Director
Not Ranked
Ranked #32,522 out of 98,564 Corporate Insiders
Craig A. Johnson has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Craig A. Johnson holds in companies
Most Profitable Insider Trade
The most profitable trade made by Craig A. Johnson
Craig A. Johnson's Trading History
Mirati Therapeutics
Jan 23, 2024
―
Uninformative Sell
―
$0.00
Odonate Inc
Dec 31, 2020
Director
Informative Buy
51.00K
$58.65M
La Jolla Pharma
Jul 12, 2022
―
Informative Buy
47.16K
$74.64K
Raptor Pharmaceutical Corp.
―
―
―
$292.32K
Pure Bioscience
―
CFO
―
$0.00
DMK Pharmaceuticals
Mar 07, 2013
Director
Uninformative Buy
―
$790.13
Heron Therapeutics
Jan 19, 2024
Director
Uninformative Buy
―
$161.26K
List of latest transactions for each holding click on a transaction to see Craig A. Johnson's performance on stock
You May Also Like
Craig A. Johnson insider profile FAQ
What is the percentage of profitable transactions made by Craig A. Johnson?
The percentage of profitable transactions made by Craig A. Johnson is ―.
What is the average return per transaction made by Craig A. Johnson?
The average return per transaction made by Craig A. Johnson is ―.
What stocks does Craig A. Johnson hold?
Craig A. Johnson holds: MRTX, ODTCD, LJPC, RPTP, PURE, DMKPQ, HRTX stocks.
What was Craig A. Johnson’s latest transaction?
Craig A. Johnson latest transaction was an Uninformative Sell of ―.
What was Craig A. Johnson's most profitable transaction?
Craig A. Johnson’s most profitable transaction was an Informative Buy of ODTCD stock on December 31, 2020. The return on the trade was -92.90%.
What is Craig A. Johnson's role in Mirati Therapeutics?
Craig A. Johnson's role in Mirati Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.